Carregant...
PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
Over the last decade, the use of targeted therapies has immensely increased in the treatment of cancer. However, treatment for endometrial carcinomas (ECs) has lagged behind, although potential molecular markers have been identified. This is particularly problematic for the type II ECs, since these...
Guardat en:
| Publicat a: | Front Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558005/ https://ncbi.nlm.nih.gov/pubmed/31214504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00462 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|